Company Filing History:
Years Active: 2001
Title: Thomas Ried: Innovator in Chromosomal Research
Introduction
Thomas Ried is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of genetics, particularly in the analysis of human chromosomes. With a total of 2 patents, his work has advanced our understanding of chromosomal behavior in various cellular contexts.
Latest Patents
One of Thomas Ried's latest patents is titled "Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization." This patent discloses a method for specifically decorating selected mammalian chromosomes and detecting, identifying, and quantifying individual chromosomes through chromosomal in situ suppression (CISS) hybridization. This method is particularly useful for analyzing cells for the presence of chromosomes, chromosome fragments, or chromosome aberrations.
Another significant patent is "Arrangement of nucleic acid sequences for comparative genomic hybridization." This invention provides a method for determining the relative number of nucleic acid sequences in test cells, ensuring high resolution during comparative genomic hybridization. It keeps all components separate and selects target nucleic acids that enhance the capability for determining genomic imbalances in test cells, facilitating the screening for over- or under-expression of individual genes.
Career Highlights
Throughout his career, Thomas Ried has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Yale University. His research has been pivotal in advancing the methodologies used in genomic analysis and chromosomal studies.
Collaborations
Thomas Ried has collaborated with notable colleagues, including Thomas Cremer and Peter Lichter. These collaborations have further enriched his research and contributed to the scientific community's understanding of genetics.
Conclusion
Thomas Ried's innovative work in chromosomal research has led to significant advancements in genetic analysis. His patents reflect a commitment to enhancing our understanding of human chromosomes and their implications in health and disease.